BOYEN THERAPEUTICS INC has a total of 12 patent applications. Its first patent ever was published in 2013. It filed its patents most often in United States, Australia and Brazil. Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are INIMMUNE CORP, HEFEI COSOURCE PHARMACEUTICALS INC and KUNMING PHARMACEUTICAL CORP.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 3 | |
#2 | Australia | 1 | |
#3 | Brazil | 1 | |
#4 | Canada | 1 | |
#5 | China | 1 | |
#6 | EPO (European Patent Office) | 1 | |
#7 | Republic of Korea | 1 | |
#8 | Singapore | 1 | |
#9 | Taiwan | 1 | |
#10 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Sugars | |
#3 | Therapeutic chemical compounds |
# | Name | Total Patents |
---|---|---|
#1 | Wu Laurence I | 10 |
#2 | Laurence I Wu | 1 |
#3 | Wu I-Chih | 1 |
Publication | Filing date | Title |
---|---|---|
TW201945008A | Novel compounds of Clofarabine derivatives, producing methods and the pharmaceutical composition thereof | |
WO2014078295A1 | Gemcitabine prodrugs and uses thereof |